Small cell lung cancer trials recruiting in Maryland

All Small cell lung cancer trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
  NCT06095505 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
  NCT06203210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
  NCT07218146 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda, Silver Spring
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
  NCT05450965 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Tempus Small Cell Lung Cancer Observational Study (Sculptor)
  NCT05257551 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
  NCT02146170 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda